BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33984160)

  • 1. Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.
    Ramírez MJ; Pujol R; Trujillo-Quintero JP; Minguillón J; Bogliolo M; Río P; Navarro S; Casado JA; Badell I; Carrasco E; Balmaña J; Català A; Sevilla J; Beléndez C; Argilés B; López M; Díaz de Heredia C; Rao G; Nicoletti E; Schwartz JD; Bueren JA; Surrallés J
    Am J Hematol; 2021 Aug; 96(8):989-999. PubMed ID: 33984160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
    Nicoletti E; Rao G; Bueren JA; Río P; Navarro S; Surrallés J; Choi G; Schwartz JD
    Ann Hematol; 2020 May; 99(5):913-924. PubMed ID: 32065290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of chromosome breakage in non-mosaic and mosaic patients with Fanconi anemia, relatives, and patients with other inherited bone marrow failure syndromes.
    Fargo JH; Rochowski A; Giri N; Savage SA; Olson SB; Alter BP
    Cytogenet Genome Res; 2014; 144(1):15-27. PubMed ID: 25227706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction.
    Gross M; Hanenberg H; Lobitz S; Friedl R; Herterich S; Dietrich R; Gruhn B; Schindler D; Hoehn H
    Cytogenet Genome Res; 2002; 98(2-3):126-35. PubMed ID: 12697994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway.
    Soulier J; Leblanc T; Larghero J; Dastot H; Shimamura A; Guardiola P; Esperou H; Ferry C; Jubert C; Feugeas JP; Henri A; Toubert A; Socié G; Baruchel A; Sigaux F; D'Andrea AD; Gluckman E
    Blood; 2005 Feb; 105(3):1329-36. PubMed ID: 15383454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic findings in Polish patients with suspected Fanconi anemia.
    Repczyńska A; Jułga K; Lorenc A; Skalska-Sadowska J; Wysocki M; Zaucha-Prażmo A; Drabko K; Bossowski A; Dembowska-Bagińska B; Wachowiak J; Buciński A; Haus O
    Adv Clin Exp Med; 2024 Apr; 33(4):361-368. PubMed ID: 37540155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic research in the crystal chromosome disease Fanconi anemia.
    Minguillón J; Surrallés J
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):104-108. PubMed ID: 30389152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact.
    Castella M; Pujol R; Callén E; Ramírez MJ; Casado JA; Talavera M; Ferro T; Muñoz A; Sevilla J; Madero L; Cela E; Beléndez C; de Heredia CD; Olivé T; de Toledo JS; Badell I; Estella J; Dasí Á; Rodríguez-Villa A; Gómez P; Tapia M; Molinés A; Figuera Á; Bueren JA; Surrallés J
    J Med Genet; 2011 Apr; 48(4):242-50. PubMed ID: 21217111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype.
    Asur RS; Kimble DC; Lach FP; Jung M; Donovan FX; Kamat A; Noonan RJ; Thomas JW; Park M; Chines P; Vlachos A; Auerbach AD; Smogorzewska A; Chandrasekharappa SC
    Mol Genet Genomic Med; 2018 Jan; 6(1):77-91. PubMed ID: 29193904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies.
    Nie D; Zhang J; Wang F; Zhang W; Liu L; Chen X; Zhang Y; Cao P; Xiong M; Wang T; Wu P; Ma X; Tian W; Wang M; Chen KN; Liu H
    BMC Med Genet; 2020 Jun; 21(1):118. PubMed ID: 32487094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal breakage study in children suspected with Fanconi anemia in the Indian population.
    Korgaonkar S; Ghosh K; Jijina F; Vundinti BR
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):606-10. PubMed ID: 20881871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Fanconi anemia in patients with bone marrow failure.
    Pinto FO; Leblanc T; Chamousset D; Le Roux G; Brethon B; Cassinat B; Larghero J; de Villartay JP; Stoppa-Lyonnet D; Baruchel A; Socié G; Gluckman E; Soulier J
    Haematologica; 2009 Apr; 94(4):487-95. PubMed ID: 19278965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I treat MDS and AML in Fanconi anemia.
    Peffault de Latour R; Soulier J
    Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell collection and gene transfer in Fanconi anemia.
    Kelly PF; Radtke S; von Kalle C; Balcik B; Bohn K; Mueller R; Schuesler T; Haren M; Reeves L; Cancelas JA; Leemhuis T; Harris R; Auerbach AD; Smith FO; Davies SM; Williams DA
    Mol Ther; 2007 Jan; 15(1):211-9. PubMed ID: 17164793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.
    Lasaga M; Río P; Vilas-Zornoza A; Planell N; Navarro S; Alignani D; Fernández-Varas B; Mouzo D; Zubicaray J; Pujol RM; Nicoletti E; Schwartz JD; Sevilla J; Ainciburi M; Ullate-Agote A; Surrallés J; Perona R; Sastre L; Prosper F; Gomez-Cabrero D; Bueren JA
    Haematologica; 2023 Oct; 108(10):2652-2663. PubMed ID: 37021532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses.
    Haworth KG; Ironside C; Ramirez MA; Weitz S; Beard BC; Schwartz JD; Adair JE; Kiem HP
    J Gene Med; 2018 Oct; 20(10-11):e3050. PubMed ID: 30129972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients.
    Lecourt S; Vanneaux V; Leblanc T; Leroux G; Ternaux B; Benbunan M; Chomienne C; Baruchel A; Marolleau JP; Gluckman E; Socié G; Soulier J; Larghero J
    Stem Cells Dev; 2010 Feb; 19(2):203-8. PubMed ID: 19572808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Gene Therapy for Fanconi Anemia.
    Río P; Navarro S; Bueren JA
    Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.